WSO - April 2023 - 478

478
International Journal of Stroke 18(4)
Discussion: Stroke is largely preventable. This study will provide evidence of the effectiveness of a mobile app to reduce
stroke risk.
Trial registration: ACTRN12621000211864.
Keywords
Stroke, prevention, protocols, epidemiology, risk factors, intervention
Received: 10 April 2022; accepted: 14 June 2022
Introduction and rationale
The rising number of people affected by stroke is due to
increases in life expectancy but also changes in the prevalence
of stroke risk factors.1 Primary prevention is the most
effective solution to reduce the burden of stroke.2 Targets
for primary prevention are well-known; INTERSTROKE
investigators reported that 90% of strokes could be
accounted for by 10 modifiable risk factors.3 Populationlevel
data from numerous countries demonstrate persistently
high prevalence of stroke risk factors,4 suggesting an
urgent need for new primary prevention strategies.
There is growing evidence of the feasibility and effectiveness
of mobile technologies to improve health, including
results of our pilot randomized controlled trial (RCT).5
Auckland University of Technology (AUT) in New Zealand
have developed the free Stroke RiskometerTM Pro application
(hereon " The App " ) that uses an individual's demographics,
health, and lifestyle data to provide absolute and
relative risk of stroke. The App's stroke risk calculation algorithm
was validated against the established Framingham
Stroke Risk Score and QStroke and found to have comparable
stroke risk prediction.6 The App incorporates several
evidence-based tools to promote behavior change aligned
with internationally recognized stroke prevention guidelines.7
These include (1) provision of feedback on absolute
risk of stroke within the next 5-10 years and relative risk
with those of a person of the same age and sex without risk
factors to motivate behavior change; (2) employment of tailored
self-management strategies including goal setting to
engage the person in behavior modification; (3) information
on stroke risk factors and warning signs aligned with the
internationally relevant Face, Arm, Speech, Time (FAST)
international mass media campaign; (4) reminders, known as
" push notifications, " to prompt users to achieve their goals
that have been shown to increase adherence to programs;8
and (5) the ability to track and visualize individual risk factors
over time. Mobile technologies are widely accessible
and promising approach to enhance primary stroke prevention
strategies.9 However, there is limited evidence of their
efficacy for changing health behaviors to prevent stroke.10
Our primary aim is to determine the efficacy of The App
in improving the Life's Simple 7 (LS7)11 score comprising
lifestyle and biomedical risk factors compared to the usual
care at 6 months post-randomization.
International Journal of Stroke, 18(4)
Methods
Design
Knowledge to reduce the risk of Stroke (PERKSInternational)
is a Phase III, prospective, pragmatic, openlabel,
single-blinded end-point, 2-arm, RCT
being
undertaken in Australia (Hobart, Tasmania; Melbourne,
Victoria; Adelaide, South Australia) and New Zealand
(Auckland, Hamilton). Mobile network coverage is high in
all locations (>96% of population). The protocol is presented
in accordance with the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)12 and
mHealth evidence reporting and assessment (mERA) guidelines
(see Supplemental Material 1).13
Participant eligibility
Participants will be recruited through advertising (Australia
and New Zealand) and General practice clinics (New
Zealand).
Inclusion criteria:
* Aged between 35 and 75 years (inclusive).
* ⩾2 " poor " LS7 risk factors.11
* No cognitive impairment (Montreal Cognitive
Assessment (MoCA) score ⩾26).14
* Own smartphone.
* Speaks English.
Exclusion criteria:
* History of stroke, myocardial infarction, or terminal
illness (self-report with verification through medical
records).
* Participating in another RCT.
* Family/household members of existing participants.
Screening is conducted online using REDCap: https://redcap.utas.edu.au/surveys/?s=M7N8DHFE3J.
Potential participants
are sent an e-mail via REDCap with links to (1)
online booking system for the face-to-face baseline assessment
for biomedical risk factors (Supplemental Table 1)
and (2) questionnaires for demographic, health, and lifestyle
questions (Supplemental Material 2).
https://redcap.utas.edu.au/surveys/?s=M7N8DHFE3J https://redcap.utas.edu.au/surveys/?s=M7N8DHFE3J

WSO - April 2023

Table of Contents for the Digital Edition of WSO - April 2023

Contents
WSO - April 2023 - Cover1
WSO - April 2023 - Cover2
WSO - April 2023 - 375
WSO - April 2023 - Contents
WSO - April 2023 - 377
WSO - April 2023 - 378
WSO - April 2023 - 379
WSO - April 2023 - 380
WSO - April 2023 - 381
WSO - April 2023 - 382
WSO - April 2023 - 383
WSO - April 2023 - 384
WSO - April 2023 - 385
WSO - April 2023 - 386
WSO - April 2023 - 387
WSO - April 2023 - 388
WSO - April 2023 - 389
WSO - April 2023 - 390
WSO - April 2023 - 391
WSO - April 2023 - 392
WSO - April 2023 - 393
WSO - April 2023 - 394
WSO - April 2023 - 395
WSO - April 2023 - 396
WSO - April 2023 - 397
WSO - April 2023 - 398
WSO - April 2023 - 399
WSO - April 2023 - 400
WSO - April 2023 - 401
WSO - April 2023 - 402
WSO - April 2023 - 403
WSO - April 2023 - 404
WSO - April 2023 - 405
WSO - April 2023 - 406
WSO - April 2023 - 407
WSO - April 2023 - 408
WSO - April 2023 - 409
WSO - April 2023 - 410
WSO - April 2023 - 411
WSO - April 2023 - 412
WSO - April 2023 - 413
WSO - April 2023 - 414
WSO - April 2023 - 415
WSO - April 2023 - 416
WSO - April 2023 - 417
WSO - April 2023 - 418
WSO - April 2023 - 419
WSO - April 2023 - 420
WSO - April 2023 - 421
WSO - April 2023 - 422
WSO - April 2023 - 423
WSO - April 2023 - 424
WSO - April 2023 - 425
WSO - April 2023 - 426
WSO - April 2023 - 427
WSO - April 2023 - 428
WSO - April 2023 - 429
WSO - April 2023 - 430
WSO - April 2023 - 431
WSO - April 2023 - 432
WSO - April 2023 - 433
WSO - April 2023 - 434
WSO - April 2023 - 435
WSO - April 2023 - 436
WSO - April 2023 - 437
WSO - April 2023 - 438
WSO - April 2023 - 439
WSO - April 2023 - 440
WSO - April 2023 - 441
WSO - April 2023 - 442
WSO - April 2023 - 443
WSO - April 2023 - 444
WSO - April 2023 - 445
WSO - April 2023 - 446
WSO - April 2023 - 447
WSO - April 2023 - 448
WSO - April 2023 - 449
WSO - April 2023 - 450
WSO - April 2023 - 451
WSO - April 2023 - 452
WSO - April 2023 - 453
WSO - April 2023 - 454
WSO - April 2023 - 455
WSO - April 2023 - 456
WSO - April 2023 - 457
WSO - April 2023 - 458
WSO - April 2023 - 459
WSO - April 2023 - 460
WSO - April 2023 - 461
WSO - April 2023 - 462
WSO - April 2023 - 463
WSO - April 2023 - 464
WSO - April 2023 - 465
WSO - April 2023 - 466
WSO - April 2023 - 467
WSO - April 2023 - 468
WSO - April 2023 - 469
WSO - April 2023 - 470
WSO - April 2023 - 471
WSO - April 2023 - 472
WSO - April 2023 - 473
WSO - April 2023 - 474
WSO - April 2023 - 475
WSO - April 2023 - 476
WSO - April 2023 - 477
WSO - April 2023 - 478
WSO - April 2023 - 479
WSO - April 2023 - 480
WSO - April 2023 - 481
WSO - April 2023 - 482
WSO - April 2023 - 483
WSO - April 2023 - 484
WSO - April 2023 - 485
WSO - April 2023 - 486
WSO - April 2023 - 487
WSO - April 2023 - 488
WSO - April 2023 - 489
WSO - April 2023 - 490
WSO - April 2023 - Cover3
WSO - April 2023 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com